{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:00:02Z","timestamp":1783393202535,"version":"3.54.6"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.hoc.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T06:34:20Z","timestamp":1603262060000},"page":"1177-1191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Supportive Care for Patients with Systemic Light Chain Amyloidosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Sandy W.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Fogaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hoc.2020.08.007_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood-2015-01-620302","article-title":"A\u00a0European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis","volume":"126","author":"Palladini","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11864-000-0018-9","article-title":"Primary systemic amyloidosis","volume":"1","author":"Comenzo","year":"2000","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2369-13-92","article-title":"The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study","volume":"13","author":"Phakdeekitcharoen","year":"2012","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.hoc.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.mcp.0000162378.35928.37","article-title":"Pleural effusions in systemic amyloidosis","volume":"11","author":"Berk","year":"2005","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis","volume":"104","author":"Pollak","year":"1993","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"issue":"18","key":"10.1016\/j.hoc.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hoc.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2019.01.035","article-title":"High prevalence of intracardiac thrombi in cardiac amyloidosis","volume":"73","author":"Martinez-Naharro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hoc.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hoc.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.hoc.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.hoc.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jce.13046","article-title":"Catheter ablation for atrial arrhythmias in patients with cardiac amyloidosis","volume":"27","author":"Tan","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.hoc.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ncpcardio0461","article-title":"Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis","volume":"3","author":"Wright","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resuscitation.2003.08.007","article-title":"Out-of-hospital cardiac arrest in patients with cardiac amyloidosis: presenting rhythms, management and outcomes in four patients","volume":"60","author":"Hess","year":"2004","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjh.14747","article-title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","volume":"182","author":"Rezk","year":"2018","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2020.08.007_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"issue":"15","key":"10.1016\/j.hoc.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A\u00a0staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.hoc.2020.08.007_bib24","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/leu.2014.227","article-title":"Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case\u2013control study on 174 patients","volume":"28","author":"Palladini","year":"2014","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.hoc.2020.08.007_bib25","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood.2019004369","article-title":"A\u00a0prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis","volume":"135","author":"Roussel","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1053\/j.ajkd.2004.08.020","article-title":"High-protein diets: potential effects on the kidney in renal health and disease","volume":"44","author":"Friedman","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.hoc.2020.08.007_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.amjmed.2011.04.013","article-title":"Cardiac amyloidosis: a practical approach to diagnosis and management","volume":"124","author":"Kapoor","year":"2011","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000339895","article-title":"Severe proteinuria secondary to amyloidosis requiring bilateral renal artery embolization","volume":"2","author":"Yeh","year":"2012","journal-title":"Case Rep Nephrol Urol"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib29","first-page":"81","article-title":"Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy","volume":"38","author":"Moroni","year":"1992","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000188738","article-title":"Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes","volume":"71","author":"Kagan","year":"1995","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000183652","article-title":"Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients","volume":"42","author":"Krediet","year":"1986","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.hoc.2020.08.007_bib32","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/archinte.1992.00400230061010","article-title":"Dialysis support of patients with primary systemic amyloidosis","volume":"152","author":"Gertz","year":"1992","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/practneurol-2018-002098","article-title":"Diagnosis of amyloid neuropathy","volume":"19","author":"Kapoor","year":"2019","journal-title":"Pract Neurol"},{"issue":"11","key":"10.1016\/j.hoc.2020.08.007_bib34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","article-title":"Orthostatic hypotension: JACC state-of-the-art review","volume":"72","author":"Freeman","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hoc.2020.08.007_bib35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0039-1688994","article-title":"Neuropathy associated with systemic amyloidosis","volume":"39","author":"Kaku","year":"2019","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/nau.20600","article-title":"Lower urinary tract dysfunction in familial amyloidotic polyneuropathy, Portuguese type","volume":"28","author":"Andrade","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mus.22178","article-title":"Bladder dysfunction in peripheral neuropathies","volume":"45","author":"Burakgazi","year":"2012","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.hoc.2020.08.007_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0025-6196(12)60634-X","article-title":"Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis","volume":"68","author":"Menke","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0002-9343(83)90874-4","article-title":"Esophageal manometry in systemic amyloidosis. A study of 30 patients","volume":"75","author":"Rubinow","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM197907053010105","article-title":"Gastrointestinal-motility dysfunction in amyloidosis","volume":"301","author":"Battle","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2020.08.007_bib41","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gut.34.10.1412","article-title":"Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein","volume":"34","author":"Tada","year":"1993","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ajg.2013.453","article-title":"A\u00a0small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial","volume":"109","author":"Olausson","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.hoc.2020.08.007_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1517\/14656566.2013.795948","article-title":"Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives","volume":"14","author":"Stevens","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"10.1016\/j.hoc.2020.08.007_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-115-7-577_1","article-title":"Octreotide for diarrhea in amyloidosis","volume":"115","author":"Yam","year":"1991","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.hoc.2020.08.007_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jnnp.55.9.860-a","article-title":"Octreotide--a new treatment for diarrhoea in familial amyloidotic polyneuropathy","volume":"55","author":"Carvalho","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0268-960X(03)00027-4","article-title":"Therapy for immunoglobulin light chain amyloidosis: the new and the old","volume":"18","author":"Gertz","year":"2004","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.hoc.2020.08.007_bib47","first-page":"365","article-title":"Enterostomy in patients with primary neuropathic amyloidosis","volume":"70","author":"Ek","year":"1978","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.hoc.2020.08.007_bib48","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1983.03330340064034","article-title":"Bleeding manifestations in 100 patients with amyloidosis","volume":"249","author":"Yood","year":"1983","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.hoc.2020.08.007_bib49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10350-004-6403-x","article-title":"Primary systemic amyloidosis presenting as a colonic stricture: successful treatment with left hemicolectomy followed by autologous hematopoietic\u00a0stem-cell transplantation: report of a case","volume":"45","author":"Rives","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.hoc.2020.08.007_bib50","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","article-title":"Autologous stem cell transplantation for primary systemic amyloidosis","volume":"99","author":"Comenzo","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ajcp\/87.3.405","article-title":"Primary amyloidosis with diffuse splenic infiltration presenting as fulminant pneumococcal sepsis","volume":"87","author":"Frank","year":"1987","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2020.08.007_bib52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcn\/83.2.350","article-title":"Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis","volume":"83","author":"Caccialanza","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2012.070359","article-title":"A\u00a0prospective study of nutritional status in immunoglobulin light chain amyloidosis","volume":"98","author":"Sattianayagam","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-011-1309-x","article-title":"Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis","volume":"91","author":"Caccialanza","year":"2012","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17474124.2018.1397511","article-title":"Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years","volume":"12","author":"Wixner","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nmd.2016.03.006","article-title":"Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy","volume":"26","author":"Russo","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib57","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.clml.2013.08.007","article-title":"Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature","volume":"14","author":"Ericson","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.hoc.2020.08.007_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.2830030303","article-title":"Coagulopathy in amyloidosis: combined deficiency of factors IX and X","volume":"3","author":"McPherson","year":"1977","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2020.08.007_bib59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0025-6196(11)65130-6","article-title":"Amyloidosis: recognition, confirmation, prognosis, and therapy","volume":"74","author":"Gertz","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.hoc.2020.08.007_bib60","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1046\/j.1365-2141.2001.02667.x","article-title":"Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency","volume":"112","author":"Boggio","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.21603","article-title":"Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients","volume":"85","author":"Thompson","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.gassur.2003.10.014","article-title":"Successful perioperative management of factor X deficiency associated with primary amyloidosis","volume":"8","author":"Takabe","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib63","first-page":"585","article-title":"Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis","volume":"14","author":"Veneri","year":"2016","journal-title":"Blood Transfus"},{"issue":"12","key":"10.1016\/j.hoc.2020.08.007_bib64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ajh.23813","article-title":"Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis","volume":"89","author":"Litvak","year":"2014","journal-title":"Am J Hematol"},{"issue":"18","key":"10.1016\/j.hoc.2020.08.007_bib65","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2014-02-556514","article-title":"Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis","volume":"123","author":"Mahmood","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.hoc.2020.08.007_bib66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM197911083011907","article-title":"Factor X deficiency in primary amyloidosis: resolution after splenectomy","volume":"301","author":"Greipp","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archinte.1983.00350030211041","article-title":"Resolution of factor X deficiency in primary amyloidosis following splenectomy","volume":"143","author":"Rosenstein","year":"1983","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ndt\/13.1.190","article-title":"Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis","volume":"13","author":"Bohrer","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.hoc.2020.08.007_bib69","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1002\/art.22959","article-title":"Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival","volume":"56","author":"Prokaeva","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.hoc.2020.08.007_bib70","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.mayocp.2016.06.027","article-title":"Systemic immunoglobulin light chain amyloidosis\u2013associated myopathy: presentation, diagnostic pitfalls, and outcome","volume":"91","author":"Muchtar","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib71","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/joim.12617","article-title":"Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis","volume":"281","author":"Muchtar","year":"2017","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2020.08.007_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hed.2880170412","article-title":"Hypothyroidism in association with systemic amyloidosis","volume":"17","author":"Rich","year":"1995","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.hoc.2020.08.007_bib73","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/000348949210100607","article-title":"Primary salivary gland amyloidosis causing sicca syndrome","volume":"101","author":"Myssiorek","year":"1992","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"10.1016\/j.hoc.2020.08.007_bib74","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0030-4220(87)90233-7","article-title":"Oral amyloidosis: two unusual case presentations","volume":"63","author":"Al-Hashimi","year":"1987","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"755","key":"10.1016\/j.hoc.2020.08.007_bib75","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/pgmj.64.755.696","article-title":"Massive macroglossia, amyloidosis and myeloma","volume":"64","author":"Jacobs","year":"1988","journal-title":"Postgrad Med J"},{"issue":"23","key":"10.1016\/j.hoc.2020.08.007_bib76","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMicm061510","article-title":"Amyloid Purpura","volume":"356","author":"Eder","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hoc.2020.08.007_bib77","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archderm.1981.01650120028015","article-title":"Bullous amyloidosis","volume":"117","author":"Westermark","year":"1981","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.hoc.2020.08.007_bib78","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","article-title":"Light chain amyloidosis: patient experience survey from the amyloidosis research consortium","volume":"32","author":"Lousada","year":"2015","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.hoc.2020.08.007_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13023-016-0564-2","article-title":"The burden of amyloid light chain amyloidosis on health-related quality of life","volume":"12","author":"Bayliss","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.hoc.2020.08.007_bib80","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/13506129.2015.1102131","article-title":"The patient's perspective on the symptom and everyday life impact of AL amyloidosis","volume":"22","author":"Lin","year":"2015","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.hoc.2020.08.007_bib81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1467-9566.ep10933316","article-title":"Renegotiating identity: cancer narratives","volume":"17","author":"Mathieson","year":"1995","journal-title":"Sociol Health Illn"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820301027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820301027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:15:19Z","timestamp":1760184919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858820301027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0889858820301027"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2020.08.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supportive Care for Patients with Systemic Light Chain Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}